Amwell

Amwell to Report Third Quarter 2021 Operating Results and Host Conference Call on Wednesday, November 10, 2021

Retrieved on: 
Monday, October 25, 2021

Amwell , (NYSE: AMWL ) (the "Company") a national telehealth leader, today announced that it will report third quarter ended September 30, 2021, operating results on Wednesday, November 10, 2021.

Key Points: 
  • Amwell , (NYSE: AMWL ) (the "Company") a national telehealth leader, today announced that it will report third quarter ended September 30, 2021, operating results on Wednesday, November 10, 2021.
  • Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update.
  • Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call.
  • American Well, Amwell, and Amwell Medical Group are registered trademarks or trademarks of American Well Corporation in the United States and other countries.

Amwell's Converge Virtual Care Platform Hailed as Best New Application in Telehealth

Retrieved on: 
Thursday, October 14, 2021

Converge is designed to offer a scalable, simple and unified digital care delivery experience across the care continuum.

Key Points: 
  • Converge is designed to offer a scalable, simple and unified digital care delivery experience across the care continuum.
  • Amwell has received positive feedback from clients using the Converge Platform following a strong initial rollout.
  • Amwell was recognized for its innovative and scalable telehealth platform scoring high on quality, safety, EHR integrations, cost and convenience.
  • The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living.

Orbita launches enhanced patient outreach solution to reduce friction and automate critical workflows for healthcare and life sciences organizations

Retrieved on: 
Thursday, October 14, 2021

BOSTON, Oct. 14, 2021 /PRNewswire/ -- Orbita , the leading provider of secure voice and chatbot virtual assistant solutions for healthcare, today announces enhanced capabilities and widespread availability of its proactive, omnichannel patient outreach solution, Orbita Outreach.

Key Points: 
  • BOSTON, Oct. 14, 2021 /PRNewswire/ -- Orbita , the leading provider of secure voice and chatbot virtual assistant solutions for healthcare, today announces enhanced capabilities and widespread availability of its proactive, omnichannel patient outreach solution, Orbita Outreach.
  • Traditional scheduling processes are not only cumbersome for healthcare staff, but frustrating for patients who expect a more seamless experience with their healthcare.
  • Orbita Outreach deploys comprehensive, omnichannel campaigns that interact with patients in a flexible, conversational way to effectively assist with appointment scheduling, Q&A and more.
  • "Not only does this improve patient experience, but our customers have seen 20-30% higher engagement rates from Orbita Outreach campaigns.

The Clinic by Cleveland Clinic and RubiconMD Announce Partnership to Advance Access to Specialty Expertise

Retrieved on: 
Tuesday, October 5, 2021

The Clinic by Cleveland Clinic , a joint venture between Cleveland Clinic and Amwell (NYSE: AMWL), and RubiconMD , a leader in virtual-first specialty care solutions, today announced a strategic partnership to democratize access to medical expertise and provide clinicians access to same-day specialist guidance in primary care settings.

Key Points: 
  • The Clinic by Cleveland Clinic , a joint venture between Cleveland Clinic and Amwell (NYSE: AMWL), and RubiconMD , a leader in virtual-first specialty care solutions, today announced a strategic partnership to democratize access to medical expertise and provide clinicians access to same-day specialist guidance in primary care settings.
  • This collaboration will utilize RubiconMDs eConsult Platform to connect primary care clinicians to a panel of Cleveland Clinics world-renowned, multidisciplinary experts.
  • For patients, the partnership offers more convenience and can potentially eliminate the need for a referral, reducing overall out-of-pocket costs.
  • Were excited to partner with RubiconMD on this initiative, which aligns directly with The Clinics vision of expanding access to the worlds best clinical expertise, said Frank McGillin, CEO of The Clinic by Cleveland Clinic.

Amwell Industry Telehealth Survey Paints Picture of an Integrated, Streamlined Digital Care Future

Retrieved on: 
Tuesday, September 28, 2021

Survey results highlight the rapid emergence of the next era of digital care.

Key Points: 
  • Survey results highlight the rapid emergence of the next era of digital care.
  • While most early telehealth use focused on urgent care, the pandemic created unprecedented volumes of Covid-19 need-driven telehealth alongside rapidly accelerated demand for scheduled virtual primary and specialty care appointments.
  • During the pandemic, telehealth proved to be a critical, and in many cases the only connection point between patients and care teams.
  • Additional key findings include:
    Shifting Focus to an Integrated, Single-Platform Strategy: A streamlined experience for patients and clinicians, interoperability and a sustainable infrastructure are essential for the future of telehealth.

BioSymetrics Expands Leadership Team to Support Rapid Growth

Retrieved on: 
Tuesday, September 28, 2021

BioSymetrics integrates clinical and experimental data using machine learning to navigate human disease biology and advance precision medicines.

Key Points: 
  • BioSymetrics integrates clinical and experimental data using machine learning to navigate human disease biology and advance precision medicines.
  • BioSymetrics is currently exploring, with and without partners, preclinical development of assets in neurogenerative, cardiovascular and rare disorders.
  • These three leadership appointments support BioSymetrics' plans to operationalize its proprietary Elion platform and accelerate partner and pipeline development:
    Stacie will guide the company on its drug discovery strategy, with a focus on human-relevant disease biology, and progressing beyond protein targets.
  • This is the team that will accelerate our growth and help elevate BioSymetrics as a leader in our industry."

Pandion Optimization Alliance Strengthens Digital Health Offering; Partners with Amwell

Retrieved on: 
Thursday, September 23, 2021

We are thrilled to partner with Amwell and extend their many digital care offerings to our growing membership base, said Dorothy Smith, VP of Corporate Development, Pandion.

Key Points: 
  • We are thrilled to partner with Amwell and extend their many digital care offerings to our growing membership base, said Dorothy Smith, VP of Corporate Development, Pandion.
  • Amwell will headline an already robust Digital Health Suite of partnerships under the Pandion family of businesses by offering members access to the best-in-class telehealth options on the market.
  • Pandion is a certified sponsor of healthcare purchasing giant, Premier, Inc.
    Pandion Optimization Alliance is a Group Purchasing Organization (GPO) and Supply Chain Consulting Company.
  • As a progressive player Pandion has positioned itself as a resource for digital health contracts and in the fast-growing e-commerce marketplace.

The Clinic by Cleveland Clinic and ReviveHealth Partner to Offer Members Virtual Second Opinions On Demand

Retrieved on: 
Tuesday, September 21, 2021

The need for second opinions in healthcare is growing, with the market for second opinions projected to reach $7 billion by 2024 , up from $2.7 billion in 2019.

Key Points: 
  • The need for second opinions in healthcare is growing, with the market for second opinions projected to reach $7 billion by 2024 , up from $2.7 billion in 2019.
  • Data from The Clinic by Cleveland Clinic shows that when patients receive a second opinion for life-altering diagnoses, such as cancer, 28% of patients receive a change in diagnosis.
  • Were excited to provide ReviveHealth members dealing with significant medical conditions the opportunity to have Cleveland Clinic expert physicians review their diagnoses and treatment plans, stated Frank McGillin, CEO of The Clinic by Cleveland Clinic.
  • Revive Plus+ members can access the virtual second opinion service through The Clinic by Cleveland Clinic after consulting with their ReviveHealth care provider.

Current Health Expands Leadership to Fuel Product Innovation and Growth

Retrieved on: 
Thursday, September 2, 2021

On the heels of record growth and $43M in series B funding, Current Health is rapidly scaling its product development efforts to provide customers with a single, end-to-end platform to deliver healthcare at home.

Key Points: 
  • On the heels of record growth and $43M in series B funding, Current Health is rapidly scaling its product development efforts to provide customers with a single, end-to-end platform to deliver healthcare at home.
  • Prior to joining Current Health, Kaufman led engineering for Amazon EMRs data plane, Amazons industry leading cloud-based data platform.
  • Kaufman takes over the CTO role from Current Health Co-Founder Steward Whiting who now serves as the companys Chief Innovation Officer.
  • Mehta joins Current Health as SVP of Product to oversee product strategy and innovation.

19Labs adds GALE | VisualVitals: Deviceless Vital Sign Measurement to GALE Point-Of-Care eClinics

Retrieved on: 
Thursday, September 2, 2021

Clinicians can leverage both FDA-approved devices and GALE | VisualVitals to diagnose patients during telehealth calls.

Key Points: 
  • Clinicians can leverage both FDA-approved devices and GALE | VisualVitals to diagnose patients during telehealth calls.
  • Patients can use GALE | VisualVitals on their own as well, to monitor well-being at their convenience.
  • The GALE open platform anonymizes the measurements, and the patient data is protected, encrypted, and secured on the tablet.
  • "GALE integrates the best diagnostic technologies from around the world to create effective, affordable, and smart point-of-care solutions," said Ram Fish, 19Labs CEO & Founder.